Telix Pharmaceuticals (TLX) Invested Capital (2023 - 2026)
Telix Pharmaceuticals (TLX) posted quarterly Invested Capital of $405.0 million for Q4 2025, up 8.5% year-over-year from $373.3 million in Q4 2024, and up 8.5% quarter-over-quarter from $373.3 million in Q4 2024.
Powered by 
Analysis
Telix Pharmaceuticals (TLX) Invested Capital (2023 - 2026) Analysis & Trends
Telix Pharmaceuticals (TLX) has reported Invested Capital for 3 consecutive years, with $405.0 million the latest figure, recorded in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Telix Pharmaceuticals | 4.03 Bn | 3.73 Bn | - | 1.00 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Bn |
| Dec 31, 2025 | 820.40 Mn |
| Dec 31, 2024 | 744.87 Mn |
| Dec 31, 2023 | 102.91 Mn |